Soleno Therapeutics, Inc(NASDAQ:SLNO) 
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release (DCCR), a once-daily oral tablet for the treatment of Prader-Wi...
Website: http://www.soleno.life
Founded: 1999
Full Time Employees: 13
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 71.39
H 73.00
L 67.13
C 67.48
V 1,270,314
10EMA 67.48
20EMA 67.48
60EMA 67.48
120EMA 67.48
250EMA 67.48